Effect of embolization in the definitive and palliative management of bone and soft tissue tumors of the extremities

Thakur, Rameshwari; Aggarwal, Vineet; Dogra, Ekta; Salaria, Amit Kumar; Bhardwaj, Ramakant; Sharma, Shashikant; Thakur, Pooja

doi:10.4103/jodp.jodp_2_21

Cited by 1 publication

(1 citation statement)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is achieved by injecting embolic agents into the arteries that supply blood to the tumor [43]. Embolization may be used alone or in combination with other treatments, such as surgery, radiation therapy, or systemic therapy [44].…”

Section: General Overview and Recommendationsmentioning

confidence: 99%

Transarterial Embolization and Percutaneous Ablation of Primary and Metastatic Soft Tissue Tumors

Shu

Lim

Fang

2023

Life

View full text Add to dashboard Cite

Soft tissue tumors (STTs) include a range of benign and malignant tumors originating from soft tissues. Transarterial and percutaneous therapies are image-guided and minimally invasive approaches for managing primary and metastatic STTs. The objective of this review is to discuss transarterial and percutaneous therapies by examining the current literature, including indications, patient selection, safety, and effectiveness. Transarterial therapies (e.g., transarterial bland embolization and transarterial chemoembolization) involve the delivery of either embolic or chemotherapeutic particles using a catheter into arteries feeding the tumor, resulting in localized tumor destruction. Percutaneous therapies (e.g., radiofrequency ablation, cryoablation, irreversible electroporation, laser ablation, and magnetic resonance-guided high-intensity focused ultrasound) involve the delivery of either hot or cold temperatures, electrical current, laser, or ultrasound to specifically target tumor cells. Both therapies have been shown to be safe and effective for reducing morbidity and local control of STTs, specifically in patients who are surgically inoperable or who are unresponsive to conventional therapies. Accurate diagnosis, staging, and histological subtype identification are crucial for treatment selection. A multidisciplinary approach, a thorough understanding of tissue anatomy and surrounding structures, as well as individualized strategies based on assessment are essential for optimal patient care.

show abstract

Section: General Overview and Recommendationsmentioning

confidence: 99%